Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × belantamab mafodotin × Clear all

Phase

Phase 1/2 7 Phase 2 5 Phase 3 1 Phase 1 1

Status

Active not recruiting 6 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Carboplatin 101 Cisplatin 97 pembrolizumab 90 Gemcitabine 82 Paclitaxel 80 Docetaxel 71 Capecitabine 60 Oxaliplatin 54 Fluorouracil 53 Specimen Handling 51 Bevacizumab 51 Radiotherapy 50 Magnetic Resonance Spectroscopy 48 Dexamethasone 44 Cyclophosphamide 43 Leucovorin 41 Pemetrexed 39 Drug Therapy 39 Irinotecan 38 Doxorubicin 37 Injections 31 Rituximab 28 Etoposide 27 Vincristine 26 Trastuzumab 26 Radiosurgery 25 Lenalidomide 25 130-nm albumin-bound paclitaxel 25 Radiation 24 Prednisone 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06679101 2026-04-22

DREAMM-10

GlaxoSmithKline

Phase 3 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡